Long-Term Effects of Ozone Treatment in Patients with Persistent Numbness and Tingling Secondary to Chemotherapy-Induced Peripheral Neuropathy. A Retrospective Study
In this retrospective report, patients with persistent numbness and tingling secondary to CIPN showed clinically relevant and long-term improvements after ozone treatment. The magnitude and duration of the observed effects merit further research and support our ongoing clinical trials.
Authors
- Damián González‐Beltrán (ORCID: https://orcid.org/0000-0002-8057-4279)
- Ángeles Cánovas-Molina (ORCID: https://orcid.org/0000-0001-8557-860X)
- Francisco Rodrı́guez-Esparragón (ORCID: https://orcid.org/0000-0003-1663-3673)
- Ignacio J. Jorge (ORCID: https://orcid.org/0000-0001-7178-5691)
- Gustavo M. Callicó (ORCID: https://orcid.org/0000-0002-3784-5504)
- Carla Antonilli (ORCID: https://orcid.org/0009-0008-0244-9748)
- Himar Fabelo (ORCID: https://orcid.org/0000-0002-9794-490X)
- Delvys Rodríguez‐Abreu (ORCID: https://orcid.org/0000-0003-0506-1366)
- Bernardino Clavo (ORCID: https://orcid.org/0000-0003-2522-1064)
- Yolanda Ramallo‐Fariña (ORCID: https://orcid.org/0000-0002-1541-3989)
- Mario Federico (ORCID: https://orcid.org/0000-0002-6184-9070)
- Saray Galván‐Ruíz
- Gretel Benítez
Institutions
- Universidad de Las Palmas de Gran Canaria (ES)
- Universidad de La Laguna (ES)
- Hospital Universitario Insular de Gran Canaria (ES)
- Instituto de Salud Carlos III (ES)
- Hospital Universitario de Gran Canaria Doctor Negrín (ES)
- Red de Investigación en Actividades Preventivas y Promoción de la Salud (ES)
- Servicio Canario de la Salud (ES)
- Fundación Canaria de Investigación Sanitaria (ES)
Publication Details
- Journal
- Integrative Cancer Therapies
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/15347354241307038
- Citations
- 6
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 6.27
Funders
- Ministerio de Ciencia e Innovación
- Fundación DISA
- Cabildo de Gran Canaria
- Instituto de Salud Carlos III
- European Regional Development Fund
- Agencia Estatal de Investigación